We've updated ourPrivacy Policyto make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read ourCookie Policyhere.

Advertisement

Latest Industry Insights

Industry Insight

How CRISPR Is Transforming High-Throughput Screening

本文将介绍中国国际广播电台的基本原理SPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.
Graphical illustration of a DNA double helix.
Industry Insight

Identifying New Therapeutic Targets for Cancer With 3D Genomics

In this interview with Anthony Schmitt PhD, senior vice president of science at Arima Genomics, we discover some of the advantages and applications of 3D genomics for fields such as cancer research and drug discovery.
An image of an RNA molecule
Industry Insight

Addressing RNA Research Challenges

In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.
A collection of yam crops on a wooden table.
Industry Insight

Agricultural Grant To Help Breed More Resilient Yams in West Africa

188金宝搏备用sat down with 2022 Illumina Agricultural Greater Good Initiative Grant winner Dr. Ranjana Bhattacharjee to learn more about her plans to use genomic analysis to improve the productivity and sustainability of yam crops.
Industry Insight

Three Noteworthy Applications of CRISPR

Only 10 years ago, Nobel prize-winning work introduced CRISPR as a new and powerful genome editing tool. Here, three noteworthy applications of the technology are highlighted.
Industry Insight

“Rewriting the Textbook” for Precision Medicine

188金宝搏备用recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
Industry Insight

Meet the Scientists Bringing Back the Extinct Tasmanian Tiger

The biotech/genetic engineering company Colossal – co-founded in 2021 by renowned geneticist Professor George Church and serial entrepreneur Ben Lamm – announced it has begun a de-extinction project of the thylacine – an Australian marsupial commonly referred to as the “Tasmanian tiger”.188金宝搏备用interviewed the team to learn more.
Industry Insight

Broadening the Adoption of Pharmacogenomic Testing

188金宝搏备用recently had the pleasure of speaking to Dr. Philip Empey, to learn more about the Pharmacogenomics Center for Excellence and how it is working to prove the clinical utility of predictive PGx testing.
Industry Insight

Exploring Flow Electroporation for Cell Engineering

188金宝搏备用spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.
Industry Insight

Combining Coding and Biology To Engineer Human Cells

To learn more about new technologies being developed for drug discovery and cell therapy,188金宝搏备用spoke to bit.bio's Dr. Farah Patell-Socha and Furqan Iqbal.

Advertisement
Baidu